Abstract
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), a new
virus from Corona viruses family, was detected in China in December
2019. The virus was suddenly and vigorously disseminated among
individuals allover the world hence the control on the virus was lost
and COVID-19 pandemic was announced. Scientists start to screen all the
available options to treat this newly evolved virus. Till now there is
no validated treatment for SARS-CoV-2 patients and all drugs are under
clinical investigation. This mini-review represents a summarized insight
for the pathophysiology and the available SARS-CoV-2 therapy with the
clinical trials associated with each drug category including antivirals,
monoclonal antibodies, anticoagulants, convalescent plasma therapy,
miscellaneous and adjuvant therapies.